ME/CFS South Australia Inc supports the needs of sufferers of Myalgic Encephalomyelitis, Chronic Fatigue Syndrome and related illnesses. We do this by providing services and information to members.
ME/CFS South Australia Inc aims to keep members informed of various research projects, diets, medications, therapies, news items, etc. All communication, both verbal and written, is merely to disseminate information and not to make recommendations or directives.
Unless otherwise stated, the views expressed on this Web site are not necessarily the official views of the Society or its Committee and are not simply an endorsement of products or services.
The treatment showdown: CDC Toolkit vs IACFS/ME Primer
Tuesday 30 October 2012
The publication of the IACFS/ME Treatment Primer “Chronic Fatigue Syndrome/Myalgic Encephalomyelitis: A Primer for Clinical Practitioners” is a landmark event. In this article we’re going to compare, section by section, the two documents.
The CFIDS Association has created some good doctor education courses in the past but only the IACFS/ME – the organization of ME/CFS professionals – has the standing to begin to attempt to challenge the CDC’s dominance in this area. The CDC with its reputation in the medical community, considerable financial assets, professionally designed website, broad reach, etc. has a distinct advantage.
With its low budget (do donate to them when you pick up the Primer), anemic website and generally low visibility outside of the ME/CFS community, the IACFS/ME hardly seems to have a chance… but it has something the CDC doesn’t have; expertise and credibility within the ME/CFS community.
A 42-page document, the Primer took two years of work from prominent ME/CFS physicians and researchers with hundreds of years of experience in CFS between them, and a $10,000 grant from Hemispherx (the producer of Ampligen) to get done. On the other hand the CDC’s 16-page, large print Toolkit, appears to have been put together by staff.
Let’s take a brief look at the basics of two documents
The IACFS/ME Treatment Primer begins with a substantial section on research findings (perhaps better moved to an appendix?) which will not be covered here. Next we compare the Diagnostic sections (including Diagnostic Tests, Exclusionary Conditions, Co-morbid Conditions, etc.) of the two treatment manuals. After that comes the Treatment sections.
The full article, with comments, can be found here.
See also our earlier (27 September) article, "Toolkit vs. Toolkit: Chronic Fatigue Syndrome", by About.com's Adrienne Dellwo.
blog comments powered by Disqus